Inventor
DE SMET CHARLES
BE12 patents
⚠️ This page may combine multiple inventors who share the name “DE SMET CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LUDWIG INST CANCER RES
10 patentsUS5612201AMar 18, 1997
Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor
LUDWIG INST CANCER RES127 citations95
US7001999B1Feb 21, 2006
Tumor associated nucleic acids and uses therefor
LUDWIG INST CANCER RES16 citations91
US6475783B1Nov 5, 2002
Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof
LUDWIG INST CANCER RES8 citations73
US5997872ADec 7, 1999
Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof
LUDWIG INST CANCER RES5 citations73
US6303756B1Oct 16, 2001
Tumor associated nucleic acids and uses therefor
LUDWIG INST CANCER RES10 citations72
US6245525B1Jun 12, 2001
Tumor associated nucleic acids and uses therefor
LUDWIG INST CANCER RES11 citations72
US6027924AFeb 22, 2000
Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof
LUDWIG INST CANCER RES1 citations62
US6794131B1Sep 21, 2004
Lage-1 tumor associated nucleic acids
LUDWIG INST CANCER RES3 citations61
US7022819B2Apr 4, 2006
Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof
LUDWIG INST CANCER RES0 citations51
US7411042B2Aug 12, 2008
Tumor associated nucleic acids and uses therefor
LUDWIG INST CANCER RES0 citations50